The DOI matches its Crossref record; 65 of the 70 references it cites were found in a registry or an index.
Mice Lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control
Open accessAbstract
p21CIP1/WAF1 is a CDK inhibitor regulated by the tumor suppressor p53 and is hypothesized to mediate G1 arrest. p53 has been suggested to derive anti-oncogenic properties from this relationship. To test these notions, we created mice lacking p21CIP1/WAF1. They develop normally and (unlike p53-/- mice) have not developed spontaneous malignancies during 7 months of observation. Nonetheless, p21-/- embryonic fibroblasts are significantly deficient in their ability to arrest in G1 in response to DNA damage and nucleotide pool perturbation. p21-/- cells also exhibit a significant growth alteration in vitro, achieving a saturation density as high as that observed in p53-/- cells. In contrast, other aspects of p53 function, such as thymocytic apoptosis and the mitotic spindle checkpoint, appear normal. These results establish the role of p21CIP1/WAF1 in the G1 checkpoint, but suggest that the anti-apoptotic and the anti-oncogenic effects of p53 are more complex.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“p21 is required for p53-mediated G1/S146, 147, 148 and also for G2/M cell cycle arrest.149”
From Census and evaluation of p53 target genes (2017) · cites this paper as [148]
Citations
Cites
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
Toshiyuki, M., & Reed, J. C. (1995) · Cell · doi:10.1016/0092-8674(95)90412-3 · Cited by 4,063
Participation of p53 protein in the cellular response to DNA damage.
Kastan, M. B., Onyekwere, O. C., Sidransky, D., Vogelstein, B., & Craig, R. W. (1991) · PubMed · Cited by 3,761
p21 is a universal inhibitor of cyclin kinases
Xiong, Y., Hannon, G., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,691
Inhibitors of mammalian G1 cyclin-dependent kinases.Preprint
Sherr, C. J., & Roberts, J. M. (1995) · Genes & Development · doi:10.1101/gad.9.10.1149 · Cited by 3,242
Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047
p53 is required for radiation-induced apoptosis in mouse thymocytes
Lowe, S. W., Schmitt, E. M., Smith, S. W., Osborne, B. A., & Jacks, T. (1993) · Nature · doi:10.1038/362847a0 · Cited by 2,864
Research works printed but not linked: 3
- Jiang, 1994, Induction of differentiation in human promyelocytic HL60 leukemia cells activates p21WAF1/CIP1 expression in the absence of p53, Oncogene, 9, 3397
- Steinman, 1994, Induction of p21 (WAFf1CIPl) during differentiation, Oncogene, 9, 3389
- Strasser, 1993, Eubcl2 transgene facilitates spontaneaous transformation of early pre-B and Ig secreting cells but not T cells, Oncogene, 8, 1
Cited by
Sorted by citations
Items 901–1,000 of 1,008
Li, D., Pakala, S. B., Reddy, S. D. N., Ohshiro, K., Peng, S., Lian, Y., Fu, S. W., & Kumar, R. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.079095 · Cited by 58
Alveolar type 2 epithelial cell senescence and radiation-induced pulmonary fibrosis
Zhou, S., Zhu, J., Zhou, P., & Gu, Y. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.999600 · Cited by 58
Human RAD9 checkpoint control/proapoptotic protein can activate transcription of p21
Yin, Y., Zhu, A., Jin, Y. J., Liu, Y., Zhang, X., Hopkins, K. M., & Lieberman, H. B. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403130101 · Cited by 56
Fukushima, T., Zapata, J. M., Singha, N. C., Thomas, M., Kress, C. L., Krajewska, M., Krajewski, S., Ronai, Z. A., Reed, J. C., & Matsuzawa, S. (2006) · Immunity · doi:10.1016/j.immuni.2005.12.002 · Cited by 56
Age-Specific Functional Epigenetic Changes in p21 and p16 in Injury-Activated Satellite Cells
Li, J., Han, S., Cousin, W., & Conboy, I. M. (2014) · Stem Cells · doi:10.1002/stem.1908 · Cited by 56
Sinicrope, F. A., Roddey, G., Lemoine, M., Ruan, S., Stephens, L. C., Frazier, M. L., Shen, Y., & Zhang, W. (1998) · PubMed · Cited by 56
p21WAF1/CIP1 Acts as a Brake in Osteoblast Differentiation
Bellosta, P., Masramon, L., Mansukhani, A., & Basilico, C. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.5.818 · Cited by 56
Inactivation of p21 by E1A Leads to the Induction of Apoptosis in DNA-Damaged Cells
Chattopadhyay, D., Ghosh, M. K., Mal, A. K., & Harter, M. L. (2001) · Journal of Virology · doi:10.1128/jvi.75.20.9844-9856.2001 · Cited by 55
p21CIP1 Controls Proliferating Cell Nuclear Antigen Level in Adult Cardiomyocytes
Engel, F. B., Hauck, L., Boehm, M., Nabel, E. G., Dietz, R., & von Harsdorf, R. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.2.555-565.2003 · Cited by 56
p21Cip1 nullizygosity increases tumor metastasis in irradiated mice.
Jackson, R. J., Engelman, R. W., Coppola, D., Cantor, A. B., Wharton, W., & Pledger, W. J. (2003) · PubMed · Cited by 56
Yang, W., Bancroft, L. K., Nicholas, C., Lozonschi, I., & Augenlicht, L. H. (2003) · PubMed · Cited by 56
p21: structure and functions associated with cyclin-CDK binding
Ball, K. L. (1997) · Springer eBooks · doi:10.1007/978-1-4615-5371-7_10 · Cited by 56
Pinto, M., Pickrell, A. M., Wang, X., Bacman, S. R., Yu, A., Hida, A., Dillon, L. M., Morton, P. D., Malek, T. R., Williams, S. L., et al. (2016) · Cell Death and Differentiation · doi:10.1038/cdd.2016.123 · Cited by 56
RBMS2 inhibits the proliferation by stabilizing P21 mRNA in breast cancer
Sun, X., Hu, Y., Wu, J., Shi, L., Zhu, L., Xi, P.-W., Wei, J., & Ding, Q. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0968-z · Cited by 55
Cdk2-dependent Inhibition of p21 Stability via a C-terminal Cyclin-binding Motif
Zhu, H., Nie, L., & Maki, C. G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m407352200 · Cited by 55
The therapeutic potential of targeting the cell cycle
Webster, K. R. (1998) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.7.6.865 · Cited by 56
Didenko, V. V., Wang, X., Yang, L., & Hornsby, P. J. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118599 · Cited by 55
Genetic Analysis of Mammalian Cyclin-Dependent Kinases and Their Inhibitors
Malumbres, M., Ortega, S., & Barbacid, M. (2000) · Biological Chemistry · doi:10.1515/bc.2000.105 · Cited by 56
Functional Analysis of a p21 Mutant (Arg94→ Trp) Identified in a Human Breast Carcinoma
Balbı́n, M., Hannon, G. J., Pendás, A. M., Ferrando, A. A., Vizoso, F. J., Fueyo, A., & López-Otı́n, C. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.26.15782 · Cited by 55
Effect of p21waf1/cip1 transgene on radiation induced apoptosis in T cells
Fotedar, R., Brickner, H., Saadatmandi, N., Rousselle, T., Diederich, L., Munshi, A., Jung, B. H., Reed, J. C., & Fotedar, A. (1999) · Oncogene · doi:10.1038/sj.onc.1202693 · Cited by 55
Ras versus cyclin-dependent kinase inhibitors
Lloyd, A. C. (1998) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(98)80060-9 · Cited by 55
Li, J., Wang, Y., Sun, Y., & Lawrence, T. S. (2002) · Radiation Research · doi:10.1667/0033-7587(2002)157[0322:wttigp]2.0.co;2 · Cited by 54
Koyano, T., Namba, M., Kobayashi, T., Nakakuni, K., Nakano, D., Fukushima, M., Nishiyama, A., & Matsuyama, M. (2019) · Scientific Reports · doi:10.1038/s41598-019-48557-8 · Cited by 55
Lessons from p53 in non-mammalian models
Lu, W.-J., & Abrams, J. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401922 · Cited by 54
MECHANISMS OF CELL-CYCLE CHECKPOINTS: AT THE CROSSROADS OF CARCINOGENESIS AND DRUG DISCOVERY*
Flatt, P. M., & Pietenpol, J. A. (2000) · Drug Metabolism Reviews · doi:10.1081/dmr-100102335 · Cited by 54
Núñez, F., Chipchase, M. D., Clarke, A. R., & Melton, D. W. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.9.1073 · Cited by 56
Molecular analysis of p21 and p27 genes in human pituitary adenomas
Ikeda, H., Yoshimoto, T., & Shida, N. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.521 · Cited by 54
Krause, K., Haugwitz, U., Wasner, M., Wiedmann, M. W., Mössner, J., & Engeland, K. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5040 · Cited by 53
Todd, C., & Reynolds, N. J. (1998) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65543-5 · Cited by 54
Friedberg, E. C. (2003) · DNA repair · doi:10.1016/s1568-7864(03)00005-3 · Cited by 54
Morozov, A., Shiyanov, P. A., Barr, E., Leiden, J. M., & Raychaudhuri, P. (1997) · Journal of Virology · doi:10.1128/jvi.71.5.3451-3457.1997 · Cited by 54
Akt takes centre stage in cell-cycle deregulation
El‐Deiry, W. S. (2001) · Nature Cell Biology · doi:10.1038/35060148 · Cited by 54
Campagne, M. V. L., & Gill, R. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00580-0 · Cited by 54
Hyka‐Nouspikel, N., Desmarais, J. A., Gokhale, P. J., Jones, M., Meuth, M., Andrews, P. W., & Nouspikel, T. P. (2012) · Stem Cells · doi:10.1002/stem.1177 · Cited by 52
Han, J., Ito, Y., Yeo, J. Y., Sucov, H. M., Maas, R. L., & Chai, Y. (2003) · Developmental Biology · doi:10.1016/s0012-1606(03)00300-2 · Cited by 53
Regulation of beta cell replication
Lee, Y. C., & Nielsen, J. H. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.08.033 · Cited by 58
Lai, L., Shin, G. Y., & Qiu, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228504 · Cited by 53
Urban, G., Golden, T. A., Aragon, I. V., Cowsert, L. M., Cooper, S. R., Dean, N. M., & Honkanen, R. E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210993200 · Cited by 51
Cell cycle regulation: Repair and regeneration in acute renal failure
Price, P. M., Megyesi, J. K., & Safirstein, R. L. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.761_8.x · Cited by 53
Interdependence between muscle differentiation and cell-cycle control
Maione, R., & Amati, P. (1997) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(96)00036-4 · Cited by 54
Kovalev, G. I., Franklin, D. S., Coffield, V. M., Xiong, Y., & Su, L. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.6.3285 · Cited by 53
Noya, F., Chien, W., Broker, T. R., & Chow, L. T. (2001) · Journal of Virology · doi:10.1128/jvi.75.13.6121-6134.2001 · Cited by 53
CDC2 is down-regulated by ionizing radiation in a p53-dependent manner.
Azzam, E. I., Toledo, S. D., Pykett, M. J., Nagasawa, H. T., & Little, J. B. (1997) · PubMed · Cited by 53
The two faces of tumor suppressor p53.
Smith, M., & Fornace, A. J. (1996) · Europe PMC (PubMed Central) · Cited by 53
Ding, J., Hughes, S. H., & Arnold, E. (1997) · Biopolymers · doi:10.1002/(sici)1097-0282(1997)44:2 · Cited by 64
Myeloid differentiation (MyD) primary response genes in hematopoiesis.
Liebermann, D., & Hoffman, B. (2003) · Oncogene · doi:10.1016/s1079-9796(03)00160-8 · Cited by 27
Biochemical and molecular mechanisms regulating apoptosis
Saini, K. S., & Walker, N. I. (1998) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006891430596 · Cited by 53
Miracco, C., Pacenti, L., Santopietro, R., BIAGIOLI, M., Fimiani, M., Perotti, R., Rubegni, P., Pirtoli, L., & Luzi, P. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20001101)88:3 · Cited by 23
Haapajärvi, T., Kivinen, L., Heiskanen, A., Bordes, C. D., Datto, M., Wang, X.-F., & Laiho, M. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4403 · Cited by 53
Joyce, N. C., & Harris, D. L. (2010) · PubMed Central · Cited by 51
G1 versus G2 cell cycle arrest after adriamycin‐induced damage in mouse Swiss3T3 cells
Siu, W. Y., Yam, C. H., & Poon, R. Y. C. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01481-7 · Cited by 52
Lunz, J. G., Tsuji, H., Nozaki, I., Murase, N., & Demetris, A. J. (2005) · Hepatology · doi:10.1002/hep.20709 · Cited by 52
Zezula, J., Sexl, V., Hutter, C., Karel, A., Schütz, W., & Freissmuth, M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.47.29967 · Cited by 52
Promotion of Cell Cycle Progression by Basic Helix-Loop-Helix E2A
Zhao, F., Vilardi, A. M., Neely, R. J., & Choi, J. K. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.18.6346-6357.2001 · Cited by 52
Viale, G., Pellegrini, C., Mazzarol, G., Maisonneuve, P., Silverman, M. L., & Bòsari, S. (1999) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199902)187:3 · Cited by 52
Hartmann, B. L., Geley, S., Loeffler, M. W., Hattmannstorfer, R., Strasser-Wozak, E. M., Auer, B., & Kofler, R. (1999) · Oncogene · doi:10.1038/sj.onc.1202339 · Cited by 52
Reinke, V., & Lozano, G. (1997) · Radiation Research · doi:10.2307/3579567 · Cited by 52
On the TRAIL from p53 to apoptosis?
Kastan, M. B. (1997) · Nature Genetics · doi:10.1038/ng1097-130 · Cited by 52
Recent advances on cyclins, CDKs and CDK inhibitors
Martı́n-Castellanos, C., & Moreno, S. (1997) · Trends in Cell Biology · doi:10.1016/s0962-8924(96)10055-6 · Cited by 52
Okuda, R., Aoshiba, K., Matsushima, H., Ogura, T., Okudela, K., & Ohashi, K. (2019) · Journal of Thoracic Disease · doi:10.21037/jtd.2019.02.11 · Cited by 49
Biguanides drugs: Past success stories and promising future for drug discovery
Grytsai, O., Myrgorodska, I., Rocchi, S., Ronco, C., & Benhida, R. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113726 · Cited by 51
Recurrent MLK4 Loss-of-Function Mutations Suppress JNK Signaling to Promote Colon Tumorigenesis
Marusiak, A. A., Stephenson, N. L., Baik, H., Trotter, E. W., Li, Y., Blyth, K., Mason, S. M., Chapman, P., Puto, L. A., Read, J. A., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-0701-t · Cited by 49
Paramio, J. M., Segrelles, C., Ruiz, S., Martín‐Caballero, J., Page, A., Martínez, J. L., Serrano, M., & Jorcano, J. L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105650200 · Cited by 51
Gomes, W. A., & Kessler, J. A. (2001) · Developmental Biology · doi:10.1006/dbio.2001.0344 · Cited by 51
Apoptosis and the cell cycle: the p53 connection
Choisy, C., & Yonish-Rouach, E. (1998) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400339 · Cited by 51
wt p53 dependent expression of a membrane-associated isoform of adenylate kinase
Collavin, L., Lazarević, D., Utrera, R., Marzinotto, S., Monte, M., & Schneider, C. (1999) · Oncogene · doi:10.1038/sj.onc.1202970 · Cited by 51
ΔMEKK3:ER* activation induces a p38α/β2-dependent cell cycle arrest at the G2 checkpoint
Garner, A. P., Weston, C. R., Todd, D. E., Balmanno, K., & Cook, S. J. (2002) · Oncogene · doi:10.1038/sj.onc.1206000 · Cited by 50
Momand, J. A., & Zambetti, G. P. (1997) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19970301)64:3 · Cited by 167
Molecular Mechanisms of Myelodysplastic Syndrome
Hirai, H. (2003) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyg037 · Cited by 51
Adachi, M., Roussel, M. F., Havenith, K., & Sherr, C. J. (1997) · Blood · doi:10.1182/blood.v90.1.126 · Cited by 51
Matsuura, K., Balmukhanov, T. S., Tauchi, H., Weemaes, C. M. R., Smeets, D. F. C. M., Chrzańowska, K., Endou, S., Matsuura, S., & Komatsu, K. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7924 · Cited by 51
Ganglioside GM3 promotes cell migration by regulating MAPK and c-Fos/AP-1
Hashiramoto, A., Mizukami, H., & Yamashita, T. (2006) · Oncogene · doi:10.1038/sj.onc.1209416 · Cited by 50
Irreversible G2-M arrest and cytoskeletal reorganization induced by cytotoxic nucleoside analogues.
Halloran, P. J., & Fenton, R. G. (1998) · PubMed · Cited by 50
The p53 Response to DNA Damage In Vivo Is Independent of DNA-Dependent Protein Kinase
Jhappan, C., Yusufzai, T. M., Anderson, S. M., Anver, M. R., & Merlino, G. T. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.11.4075-4083.2000 · Cited by 50
The Growth-Regulatory Role of p21 (WAF1/CIP1)
Gartel, A. L., & Tyner, A. L. (1998) · Progress in molecular and subcellular biology · doi:10.1007/978-3-642-72149-6_4 · Cited by 49
Bulavin, D. V., Tararova, N. D., Aksenov, N. D., Pospelov, V. A., & Pospelova, T. V. (1999) · Oncogene · doi:10.1038/sj.onc.1202945 · Cited by 50
Maeda, S., Wada, H., Naito, Y., Nagano, H., Simmons, S., Kagawa, Y., Naito, A., Kikuta, J., Ishii, T., Tomimaru, Y., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.551879 · Cited by 48
McVean, M., Weinberg, W. C., & Pelling, J. C. (2002) · Molecular Carcinogenesis · doi:10.1002/mc.10016 · Cited by 49
Chen, F., & Harrison, L. E. (2004) · Cellular Signalling · doi:10.1016/j.cellsig.2004.11.002 · Cited by 49
Implications of p53 Protein Expression in Experimental Spinal Cord Injury
SAITO, N., YAMAMOTO, T., Watanabe, T., ABE, Y., & Kumagai, T. (2000) · Journal of Neurotrauma · doi:10.1089/neu.2000.17.173 · Cited by 49
Brizzi, M. F., Dentelli, P., Rosso, A., Calvi, C., Gambino, R., Cassader, M., Salvidio, G., Deferrari, G., Camussi, G., Pegoraro, L., et al. (2004) · The FASEB Journal · doi:10.1096/fj.03-1053fje · Cited by 49
p21Cip-1/SDI-1/WAF-1 Gene Is Involved in Chondrogenic Differentiation of ATDC5 Cells in Vitro
Negishi, Y., Ui, N., Nakajima, M., Kawashima, K., Maruyama, K., 知子, 滝., & Endo, H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010127200 · Cited by 49
Cell cycle regulation during mouse olfactory neurogenesis.
Legrier, M.-E., Ducray, A., Propper, A. Y., Chao, M. V., & Kästner, A. (2001) · PubMed · Cited by 49
Nrg1/ErbB signaling‐mediated regulation of fibrosis after myocardial infarction
Shiraishi, M., Yamaguchi, A., & Suzuki, K. (2022) · The FASEB Journal · doi:10.1096/fj.202101428rr · Cited by 48
Schemmer, J., Araúzo-Bravo, M. J., Haas, N., Schäfer, S., Weber, S. N., Becker, A., Eckert, D., Zimmer, A., Nettersheim, D., & Schorle, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071113 · Cited by 48
Zhao, Y. L., Ling, F., Wang, H.-C., & Sun, X.-H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055552 · Cited by 47
Sheng, G. G., Bernabe, K. Q., Guo, J., & Warner, B. W. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.05.007 · Cited by 48
Fischler, T., Li, Y., Wang, R.-H., Kim, H.-S., Sengupta, K., Vassilopoulos, A., Lahusen, T. J., Xu, X., Lee, M.-H., Liu, Q., et al. (2010) · Oncogene · doi:10.1038/onc.2010.163 · Cited by 47
Self-citationValledor, A. F., Arpa, L., Sànchez‐Tilló, E., Comalada, M., Casals, C., Xaus, J., Caelles, C., Lloberas, J., & Celada, A. (2008) · Blood · doi:10.1182/blood-2007-11-123604 · Cited by 48
14-3-3ε Plays a Role in Cardiac Ventricular Compaction by Regulating the Cardiomyocyte Cell Cycle
Kosaka, Y., Cieslik, K. A., Li, L., Lezin, G., Maguire, C. T., Saijoh, Y., Toyo‐oka, K., Gambello, M. J., Vatta, M., Wynshaw-Boris, A. J., et al. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.00829-12 · Cited by 48
p53 and RAD9, the DNA Damage Response, and Regulation of Transcription Networks
Lieberman, H. B., Panigrahi, S. K., Hopkins, K. M., Wang, L., & Broustas, C. G. (2017) · Radiation Research · doi:10.1667/rr003cc.1 · Cited by 47
Maternal diabetes induces senescence and neural tube defects sensitive to the senomorphic rapamycin
Xu, C., Shen, W., Reece, E. A., Hasuwa, H., Harman, C. R., Kaushal, S., & Yang, P. (2021) · Science Advances · doi:10.1126/sciadv.abf5089 · Cited by 45
Early Events in the DNA Damage Response
Ward, I. M., & Chen, J. (2004) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/s0070-2153(04)63001-8 · Cited by 50
A role for p53 in terminal epithelial cell differentiation
Saifudeen, Z. R., Dipp, S., & El-Dahr, S. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci13972 · Cited by 53
Inactivation of MyoD-mediated expression of p21 in tumor cell lines.
Otten, A. D., Firpo, E. J., Gerber, A. N., Brody, L. L., Roberts, J. M., & Tapscott, S. J. (1997) · PubMed · Cited by 48
Kim, S. S., Cao, L., Li, C., Xu, X., Huber, L. J., Chodosh, L. A., & Deng, C. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.21.9498-9507.2004 · Cited by 50
Self-citationFenretinide: A p53-independent way to kill cancer cells
Corazzari, M., Lovat, P. E., Oliverio, S., Sano, F. D., Donnorso, R. P., Redfern, C. P. F., & Piacentini, M. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.184 · Cited by 48
IFN Regulatory Factor 8 Regulates MDM2 in Germinal Center B Cells
Zhou, J. X., Lee, C. H., Qi, C. F., Wang, H., Naghashfar, Z., Abbasi, S., & Morse, H. C. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803693 · Cited by 47
Sheng, C., Mendler, I.-H., Rieke, S., Snyder, P., Jentsch, M., Friedrich, D., Drossel, B., & Loewer, A. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.03.031 · Cited by 45
Mansilla, S. F., Bertolin, A. P., Bergoglio, V., Pillaire, M.-J., González Besteiro, M. A., Luzzani, C., Miriuka, S. G., Cazaux, C., Hoffmann, J.-S., & Gottifredi, V. (2016) · eLife · doi:10.7554/elife.18020 · Cited by 43
Metadata
- Authors
- Deng, C., Zhang, P., Wade Harper, J., Elledge, S. J., & Leder, P.
- Affiliations
- Baylor College of Medicine (US)
- Howard Hughes Medical Institute (US)
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 1995-08
- Volume
- 82
- Issue
- 4
- Pages
- 675-684
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W2044057392
- Cited by
- 2,113
- References
- 70
- Citations by year
- 2026: 20 · 2025: 20 · 2024: 32 · 2023: 32 · 2022: 34 · 2021: 40 · 2020: 38 · 2019: 40 · 2018: 43 · 2017: 36 · 2016: 37 · 2015: 34 · 2014: 57 · 2013: 39 · 2012: 65
- FWCI
- 61.04
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institutes of Health
- National Institute on Aging (AG11085, R01AG011085)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Keywords
- p21, p53, G1/S checkpoint, cyclin-dependent kinase inhibitors, DNA damage response, embryonic fibroblasts, cell growth, thymocyte apoptosis, mitotic spindle checkpoint, tumor suppression
- MeSH terms
- Animals, Base Sequence, Cell Differentiation, Cell Division, Cell Line, DNA, DNA Damage, Spindle Apparatus, Molecular Sequence Data, Neoplasms, Experimental, Genes, p53, Tumor Suppressor Protein p53, G1 Phase, Cyclins, Apoptosis, Cyclin-Dependent Kinase Inhibitor p21, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review